RxDoctor Payments Data

Melissa Konovsky

Family · Canton, OHNPI 1669919924

Payments from drug & device makers

$1,366in general payments, 2019–2025

Across 70 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$398
  • AbbVie$192
  • Urogen Pharma, Inc.$157
  • Urovant Sciences Inc$134
  • Axonics, Inc.$130
  • Endo Pharmaceuticals Inc.$124
  • plus $230 from 6 others

What the payments were for

  • Food & beverage$1,366100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,366 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$17,550
Medicare patients
201
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron58$48,224
MyrbetriqMirabegron53$36,771
Tamsulosin Hcl429$4,855
Oxybutynin Chloride ErOxybutynin Chloride168$4,019
Cefdinir101$974
Alfuzosin Hcl ErAlfuzosin Hcl22$795
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst81$792
Finasteride78$750
NitrofurantoinNitrofurantoin Macrocrystal22$691
Trospium Chloride12$506
Trimethoprim11$403
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$269
Doxazosin Mesylate16$173
Ciprofloxacin Hcl26$165
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim28$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$398$36,77153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →